LIFECELL CORP
S-3, EX-5.1, 2000-09-05
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: LIFECELL CORP, S-3, 2000-09-05
Next: LIFECELL CORP, S-3, EX-23.1, 2000-09-05



                                                                     Exhibit 5.1


                                September 5, 2000

LifeCell  Corporation
1  Millennium  Way
Branchburg,  NJ  08876

Dear  Sirs:

     In  connection  with  the registration under the Securities Act of 1933, as
amended  (the  "Act"),  of an aggregate of 2,810,771 shares of common stock (the
"Shares"),  par  value  $.01  per  share,  of  LifeCell  Corporation, a Delaware
corporation,  upon  issuance,  we  have  examined  such  corporate  records,
certificates and other documents and such questions of law as we have considered
necessary  or  appropriate  for  the  purposes  of  this  opinion.

     Upon the basis of such examination, we advise you that, in our opinion, the
Shares  have  been  duly  authorized  and, upon issuance of those Shares not yet
issued, all of the Shares will be validly issued, fully paid and non-assessable.

     We  hereby  consent  to  the  filing  of  this opinion as an exhibit to the
Registration  Statement  and  to  the  references to this firm under the heading
"Legal  Matters"  in  the Prospectus.  In giving such consent, we do not thereby
admit  that  we  are  in the category of persons whose consent is required under
Section  7  of  the  Act.

                                               Very  truly  yours,

                                               Lowenstein  Sandler  PC


<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission